BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34621674)

  • 1. Assessment of Intratumor Heterogeneity in Parametric Dynamic Contrast-Enhanced MR Images: A Comparative Study of Novel and Established Methods.
    Gaustad JV; Rofstad EK
    Front Oncol; 2021; 11():722773. PubMed ID: 34621674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts.
    Wegner CS; Hauge A; Simonsen TG; Gaustad JV; Andersen LMK; Rofstad EK
    Neoplasia; 2018 Jul; 20(7):734-744. PubMed ID: 29886124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cluster analysis of quantitative parametric maps from DCE-MRI: application in evaluating heterogeneity of tumor response to antiangiogenic treatment.
    Longo DL; Dastrù W; Consolino L; Espak M; Arigoni M; Cavallo F; Aime S
    Magn Reson Imaging; 2015 Jul; 33(6):725-36. PubMed ID: 25839393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma.
    Klaassen R; Gurney-Champion OJ; Wilmink JW; Besselink MG; Engelbrecht MRW; Stoker J; Nederveen AJ; van Laarhoven HWM
    Magn Reson Imaging; 2018 Jul; 50():1-9. PubMed ID: 29476781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy.
    Wu J; Gong G; Cui Y; Li R
    J Magn Reson Imaging; 2016 Nov; 44(5):1107-1115. PubMed ID: 27080586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in intratumor heterogeneity in blood perfusion in intradermal human melanoma xenografts during tumor growth assessed by DCE-MRI.
    Graff BA; Benjaminsen IC; Melås EA; Brurberg KG; Rofstad EK
    Magn Reson Imaging; 2005 Nov; 23(9):961-6. PubMed ID: 16310112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted and dynamic contrast-enhanced MRI of pancreatic adenocarcinoma xenografts: associations with tumor differentiation and collagen content.
    Wegner CS; Gaustad JV; Andersen LM; Simonsen TG; Rofstad EK
    J Transl Med; 2016 Jun; 14(1):161. PubMed ID: 27268062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of temporal parameters of DCE-MRI on the quantification of heterogeneity in tumor vascularization.
    Crombé A; Saut O; Guigui J; Italiano A; Buy X; Kind M
    J Magn Reson Imaging; 2019 Dec; 50(6):1773-1788. PubMed ID: 30980697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging.
    Gaustad JV; Benjaminsen IC; Graff BA; Brurberg KG; Ruud EB; Rofstad EK
    J Magn Reson Imaging; 2005 Jun; 21(6):792-800. PubMed ID: 15906326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: assessment by voxel analysis of dynamic contrast-enhanced MRI.
    Li KL; Wilmes LJ; Henry RG; Pallavicini MG; Park JW; Hu-Lowe DD; McShane TM; Shalinsky DR; Fu YJ; Brasch RC; Hylton NM
    J Magn Reson Imaging; 2005 Oct; 22(4):511-9. PubMed ID: 16161072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Intratumor Heterogeneity of Immunohistochemistry Biomarkers to Classify Laryngeal and Hypopharyngeal Tumors Based on Histologic Features.
    Smits HJG; Ruiter LN; Breimer GE; Willems SM; Philippens MEP
    Mod Pathol; 2023 Aug; 36(8):100199. PubMed ID: 37116830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascularization, Oxygenation, and the Effect of Sunitinib Treatment in Pancreatic Ductal Adenocarcinoma Xenografts.
    Gaustad JV; Simonsen TG; Wegner CS; Rofstad EK
    Front Oncol; 2019; 9():845. PubMed ID: 31555596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging.
    Hayes C; Padhani AR; Leach MO
    NMR Biomed; 2002 Apr; 15(2):154-63. PubMed ID: 11870911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non-Small Cell Lung Cancer.
    Tixier F; Vriens D; Cheze-Le Rest C; Hatt M; Disselhorst JA; Oyen WJ; de Geus-Oei LF; Visser EP; Visvikis D
    J Nucl Med; 2016 Jul; 57(7):1033-9. PubMed ID: 26966161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Texture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancer.
    Jansen JF; Lu Y; Gupta G; Lee NY; Stambuk HE; Mazaheri Y; Deasy JO; Shukla-Dave A
    World J Radiol; 2016 Jan; 8(1):90-7. PubMed ID: 26834947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumor heterogeneity in perfusion in human melanoma xenografts measured by contrast-enhanced magnetic resonance imaging.
    Bjørnaes I; Lyng H; Dahle GA; Kaalhus O; Rofstad EK
    Magn Reson Imaging; 2000 Oct; 18(8):997-1002. PubMed ID: 11121704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic fractal signature dissimilarity analysis for therapeutic response assessment using dynamic contrast-enhanced MRI.
    Wang C; Subashi E; Yin FF; Chang Z
    Med Phys; 2016 Mar; 43(3):1335-47. PubMed ID: 26936718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric MR imaging detects therapy efficacy of radioactive seeds brachytherapy in pancreatic ductal adenocarcinoma xenografts.
    Liu Y; Wang Y; Tang W; Jiang M; Li K; Tao X
    Radiol Med; 2018 Jul; 123(7):481-488. PubMed ID: 29508241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging.
    Graff BA; Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
    J Magn Reson Imaging; 2005 Mar; 21(3):272-81. PubMed ID: 15723369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.